Abstract
BackgroundMacrophages are pivotal to the pathogenesis of rheumatoid arthritis (RA), and their inflammatory products drive many of the signs and symptoms of disease. Mavrilimumab inhibits macrophage activation and survival via...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have